Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance

Chinese Journal of Pathology

Volumn 37, Issue 2, 2008, Pages 109-113

  Wu, Zheng Sheng ^b   Wu, Qiang ^a   Ding, Xiang Dong ^b   Wang, Hong Qun ^b   Shen, Yu Xian ^b   Fang, Sheng Yun ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Breast neoplasms; Neoplasm metastasis; Prognosis; Receptors, estrogen; Xenopus proteins

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; METASTASIS; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; RELAPSE FREE SURVIVAL; STATISTICAL SIGNIFICANCE; TISSUE CHIP; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM METASTASIS; PROGNOSIS;

ANTINEOPLASTIC AGENTS, HORMONAL; BRCA2 PROTEIN; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROTEINS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; BIOMARKERS, TUMOR;

EID: 41849117677     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Liu D, Rudland PS, Sibson DR, et al. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res, 2005, 65(9):3796-3805.
2. Thompson DA, Weigel RJ. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun, 1998, 251(1):111-116.
3. Tavassoli EF, Devilee//World Health Organization classification of tumors. Pathology and genetics of tumors of the breast and female genital organs. Lyon: IARC Press, 2003.
4. Fritzsche FR, Dahl E, Pahl S, et al. Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res, 2006, 12(6):1728-1734.
5. Chinese source
6. Middleton LP, Amin M, Gwyn K, et al. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer, 2003, 98(5):1055-1060.
7. Shak S. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol, 1999, 26(4 Suppl 12):71-77.
8. Aberger F, Weidinger G, Grunz H, et al. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev, 1998, 72(1-2):115-130.
9. Huber M, Bahr I, Krätzschmar JR, et al. Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r. Mol Cell Proteomics, 2004, 3(1):43-55.
10. Thompson DA, Weigel RJ. HAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun, 1998, 251(1):111-116.
11. Innes HE, Liu D, Barraclough R, et al. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br J Cancer, 2006, 94(7):1057-1065.